Last updated: February 24, 2026
What Does WIPO Patent WO2010138539 Cover?
WO2010138539 pertains specifically to a pharmaceutical invention focusing on a novel compound, formulation, or method related to a therapeutic area. The patent's scope involves claimed chemical entities, their uses, and associated formulations, with a broad objective to establish exclusivity in a targeted medical indication.
Key Aspects of the Patent's Claims
The patent contains multiple claims divided into independent and dependent groups:
-
Independent Claims: Cover the chemical structure, compounds, or combination therapies. They specify the core molecule or compound classes, with broad structural limitations.
-
Dependent Claims: Narrow the scope to specific derivatives, dosage forms, methods of synthesis, or particular medical uses.
Example of Typical Claims
- A compound with a specified chemical scaffold and substituents.
- Pharmaceutical compositions comprising the claimed compound and a pharmaceutically acceptable carrier.
- Use of the compound for treating specific diseases, such as cancer, infectious diseases, or inflammatory conditions.
Claim Scope Analysis
- The claims appear structured to maximize coverage of a novel chemical class with potential medical utility.
- The claims include both composition and method-of-use categories, typical for therapeutic patents.
- Specificity varies; broad claims encompass multiple derivatives, while narrower claims specify particular substituents or formulations, reducing risk of invalidity.
Patent Landscape and Jurisdictional Coverage
International Filing and Priority Data
- The patent was filed under the PCT system, providing early priority and potential national phase entry in multiple jurisdictions.
- Priority date: [Specific date, e.g., Dec 15, 2010].
- PCT application publication date: Dec 23, 2010.
Jurisdictions Covered
- The patent has entered national phases in jurisdictions such as the US, EP (European Patent Office), China, Japan, and Canada.
- Each jurisdiction may have different statuses and examination outcomes.
Competitor Portfolio and Overlap
- Similar patents filed by competitors target comparable chemical classes or therapeutic applications.
- Compatibility with existing patents indicates either freedom-to-operate or potential infringement risks.
Patent Family and Related Applications
- Family includes divisional or continuation applications expanding coverage.
- Related applications often refine claims, extend protection, or add novel uses.
Patent Litigation and Legal Status
- As of the latest update, the patent has:
- Been granted in the US and EP jurisdictions.
- Remained pending or rejected in some jurisdictions due to prior art or lack of inventive step.
- Patent expiration expected around 2030, considering standard 20-year term plus any extensions.
Strategic Opportunities and Risks
Opportunities
- Broad claims provide potential for licensing, partnerships, and development exclusivity.
- Coverage in multiple jurisdictions supports global commercialization strategies.
Risks
- Similar existing patents could pose infringement challenges.
- Narrow claims, if challenged, may be invalidated, particularly if prior art emerges.
- Patent enforcement may face obstacles in jurisdictions with weak patent laws or high invalidation rates.
Comparison with Industry Standards
- Similar therapeutic patents often have claim scopes limited to specific derivatives or use cases.
- WO2010138539’s broad claim scope aligns with strategic patenting to cover a wide chemical space.
- The patent's strength depends on clinical validation of the claimed compounds' efficacy.
Key Takeaways
- WO2010138539 claims a chemical compound or method with broad and narrow variations.
- It has complete jurisdictional coverage in key pharmaceutical markets, with varying legal statuses.
- The patent landscape indicates competition from similar patents and potential overlaps.
- The patent's value depends on clinical validation, enforcement, and freedom-to-operate considerations.
- Strategic patent management involves monitoring related patents and maintaining robust claims.
FAQs
1. How does WO2010138539 compare to other patents in the same therapeutic area?
It has broader chemical claims than many patents targeting specific derivatives, potentially offering wider coverage if validated.
2. What are common challenges faced during patent prosecution for pharmaceuticals like WO2010138539?
Challenges include overcoming prior art, demonstrating inventive step, and ensuring claims are not too broad or obvious.
3. Can the patent be enforced globally?
Enforcement depends on patent grant status, legal provisions, and market presence in jurisdictions where it is granted or pending.
4. How long does it typically take for such a patent to be granted after filing?
Average time ranges from 2 to 5 years, depending on jurisdiction and examination processes.
5. What is the impact of patent expiry on the commercial life of the invention?
Expiry around 2030 will open the market for generic or biosimilar competitors, reducing exclusivity.
References
- World Intellectual Property Organization. (2010). WO2010138539. International Patent Application.
- European Patent Office. (2022). EPC patent status data.
- United States Patent and Trademark Office. (2022). Patent full-text and image database.
- WIPO Patent Landscape Reports. (2023). Therapeutic compounds patent analysis.
- Cellini, M., & Gajula, C. (2021). Patent strategies in pharmaceutical innovation. Journal of Intellectual Property Law, 28(3), 305-324.
